Related Experiment Video
Updated: Jun 21, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Weighing risk: the expert committee's recommendations in practice
Sandra G Hassink1, Pediatric Expert Panel
1Thomas Jefferson Medical School, Pediatric Weight Management Clinic, AI DuPont Hospital for Children, Wilmington, Delaware 19899, USA. shassink@nemours.org
Abstract:
In 2005, an expert committee was convened on behalf of the American Medical Association, the Health Resources and Service Administration, and the Centers for Disease Control and Prevention to update the previous recommendations on the evaluation and treatment of childhood obesity. Fifteen national health care organizations, which served children, participated in writing these recommendations. This article reviews recommendations on assessment of BMI, nutrition and activity, and obesity-related comorbidities. Principles of obesity prevention and treatment are discussed and high-risk eating and activity behaviors are addressed. Prevention and treatment of obesity are reviewed as set in the context of the Medical Home using the principles of the chronic disease model. The stepwise approach to obesity treatment and prevention is reviewed along with specific evidence-based/informed strategies. The skills needed to implement the recommendations, such as integration of the care team, roles and training, links to the health care system, connection to the community, and the role of the subspecialist, are discussed.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Weighted Mean
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Design Consideration
The factor of safety is another key aspect...
Hazard Analysis and Critical Control Points (HACCP)